This is a Validated Antibody Database (VAD) review about human HLA-DRB1, based on 133 published articles (read how Labome selects the articles), using HLA-DRB1 antibody in all methods. It is aimed to help Labome visitors find the most suited HLA-DRB1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HLA-DRB1 synonym: DRB1; HLA-DR1B; HLA-DRB; SS1

BioLegend
mouse monoclonal (L243)
  • flow cytometry; human; 3:50; loading ...; fig 1c
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 3:50 (fig 1c). Science (2020) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s20
BioLegend HLA-DRB1 antibody (Biolegend, 307640) was used in flow cytometry on human samples (fig s20). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s6c
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s6c). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s2d
BioLegend HLA-DRB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig s2d). Cell (2019) ncbi
mouse monoclonal (L243)
  • other; human; loading ...; fig 4b
BioLegend HLA-DRB1 antibody (BioLegend, 307659) was used in other on human samples (fig 4b). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1b
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1b). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). BMC Res Notes (2019) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2b
BioLegend HLA-DRB1 antibody (Biolegend, 307602) was used in mass cytometry on human samples (fig 2b). Cell (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 2 ug/ml; loading ...; fig s13
BioLegend HLA-DRB1 antibody (BioLegend, 307623) was used in flow cytometry on human samples at 2 ug/ml (fig s13). Science (2019) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 3g
BioLegend HLA-DRB1 antibody (Biolegend, 327014) was used in flow cytometry on human samples (fig 3g). Science (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3a
BioLegend HLA-DRB1 antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (Biolegend, LN3) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig 1b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:200 (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3k
BioLegend HLA-DRB1 antibody (Biolegend, 307618) was used in flow cytometry on human samples (fig s3k). Cell Rep (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 3b
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 3b). J Clin Invest (2019) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 4a
BioLegend HLA-DRB1 antibody (BioLegend, 307618) was used in flow cytometry on human samples (fig 4a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1c
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 1a). Cell (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s2d
BioLegend HLA-DRB1 antibody (BioLegend, 307624) was used in flow cytometry on human samples (fig s2d). Nat Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1a). J Immunol (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3b). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). J Clin Invest (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
BioLegend HLA-DRB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples (fig 1a). Nucleic Acids Res (2018) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig s2b
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig s2b). Nat Med (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1). J Biol Chem (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 4a
BioLegend HLA-DRB1 antibody (BioLegend, H243) was used in flow cytometry on human samples (fig 4a). Int J Infect Dis (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 1b). JCI Insight (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3b). Oncol Lett (2018) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1a
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1a). J Exp Med (2018) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; loading ...
In order to define the transcriptional network specifies conferring microglia identity, BioLegend HLA-DRB1 antibody (BioLegend, 307616) was used in flow cytometry on human samples at 1:50. Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl s3
In order to conduct a phenotypical investigation of clear cell renal cell carcinoma, BioLegend HLA-DRB1 antibody (biolegend, L243) was used in flow cytometry on human samples (tbl s3). Cell (2017) ncbi
mouse monoclonal (L243)
  • mass cytometry; human; loading ...; fig 1h
  • flow cytometry; human
In order to map the lineage of human dendritic cells, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in mass cytometry on human samples (fig 1h) and in flow cytometry on human samples . Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s6a
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2e
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2e). Oncoimmunology (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1d
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples at 1:200 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to analyze B-cell responses to meningococcal polysaccharide and conjugate vaccines against Neisseria meningitidis, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). Genome Med (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 2d
In order to study the impact of modulating IFN-I signaling during suppressive combined antiretroviral therapy, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 2d). J Clin Invest (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; rhesus macaque; loading ...; fig 7a
In order to study the efficacy of nanoparticle adjuvants for inducing protective immunity against simian immunodeficiency virus, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on rhesus macaque samples (fig 7a). J Virol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to demonstrate that freezing already-stained samples suspended in 10% DMSO in FBS is practical and efficient way to preserve already-stained samples for mass cytometry assessment, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry A (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3b). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
In order to identify RLTPR in patients and determine the effects of these mutations on CD4 positive T cells, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2a
BioLegend HLA-DRB1 antibody (BioLegend, 307606) was used in flow cytometry on human samples (fig 2a). Oncogene (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; mouse; loading ...; fig 1c
In order to test if Mincle signaling drives intrahepatic inflammation and liver injury in Con A hepatitis, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on mouse samples (fig 1c). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 2
In order to identify peanut proteins that can predict peanut allergy., BioLegend HLA-DRB1 antibody (Biolegend, 307624) was used in flow cytometry on human samples (tbl 2). J Allergy Clin Immunol (2017) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
In order to elucidate the mechanisms by which DRibbles induce T-cell activation, BioLegend HLA-DRB1 antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1b
In order to ask if CD2 is involved in the response of adaptive natural killer cells to HCMV, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 1b). Eur J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 6a
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 6a). J Biol Chem (2016) ncbi
mouse monoclonal (LN3)
  • immunocytochemistry; human; 0.5 ug/ml; fig 1
In order to assess how spore movement of Bacillus anthracis does not require a carrier cell and is not affected by lethal toxin in human lung models, BioLegend HLA-DRB1 antibody (Biolegend, 327002) was used in immunocytochemistry on human samples at 0.5 ug/ml (fig 1). Microbes Infect (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 2b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 2b). PLoS ONE (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 7a
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 7a). J Biol Chem (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s3
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s3). Nature (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; loading ...; tbl 1
BioLegend HLA-DRB1 antibody (BioLegend, LN3) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (Tu39)
  • flow cytometry; human; loading ...; tbl 1
BioLegend HLA-DRB1 antibody (BioLegend, Tu39) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 3
In order to study the pharmacologic inhibition of PI3K and MEK pathways in mixed cultures of human mononuclear cells., BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Am J Transplant (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; 1:400; fig 2
BioLegend HLA-DRB1 antibody (Biolegend, LN3) was used in flow cytometry on human samples at 1:400 (fig 2). PLoS ONE (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s1c
  • immunocytochemistry; human
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s1c) and in immunocytochemistry on human samples . J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:200; loading ...; fig s1a
In order to find that central nervous system infiltration of peripheral monocytes correlates with improved motor neuron survival in a genetic amyotrophic lateral sclerosis mouse model, BioLegend HLA-DRB1 antibody (Biolegend, 307616) was used in flow cytometry on human samples at 1:200 (fig s1a). Acta Neuropathol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig s6a
In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig s6a). Oncotarget (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; 1:20; fig 2
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples at 1:20 (fig 2). Nat Commun (2016) ncbi
mouse monoclonal (L243)
  • other; human; loading ...; fig st1
  • flow cytometry; human; loading ...; fig st3
In order to use size exclusion chromatography-microsphere-based affinity proteomics to study clinical samples obtained from pediatric acute leukemia patients, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in other on human samples (fig st1) and in flow cytometry on human samples (fig st3). Mol Cell Proteomics (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 1a
In order to study the role of human head and neck squamous cell carcinoma-associated semaphorin 4d in myeloid-derived suppressor cells, BioLegend HLA-DRB1 antibody (BioLegend, 307610) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig s1b
In order to study age-related changes in human immunity during a primary virus infection experimentally induced by immunization with live-attenuated yellow fever vaccine, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig s1b). J Immunol (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
BioLegend HLA-DRB1 antibody (Biolegend, 307628) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . Clin Cancer Res (2016) ncbi
mouse monoclonal (LN3)
  • flow cytometry; human; fig 1
In order to assess the CD4/CD8 ratio as a marker for CD4+ T cell dysfunction in chronic HIV infection, BioLegend HLA-DRB1 antibody (Biolegend, clone LN3) was used in flow cytometry on human samples (fig 1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the cell surface markers in synovial mesenchymal stem cells, BioLegend HLA-DRB1 antibody (Biolegend, 307604) was used in flow cytometry on human samples . Cytometry A (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 2a
In order to investigate the effect of thymosin on HL-60 cell maturation, BioLegend HLA-DRB1 antibody (Biolegend, 307602) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; tbl 1
In order to compare the use of CD229, CD54, and CD319 expression for the identification of normal and aberrant plasma cells, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (tbl 1). Cytometry B Clin Cytom (2016) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
In order to investigate the dynamics and characteristics of natural killer cell types in the human ocular mucosal surface in situ during infection with group D human adenoviruses, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 3). Mucosal Immunol (2016) ncbi
mouse monoclonal (Tu39)
  • flow cytometry; human
BioLegend HLA-DRB1 antibody (Biolegend, #361703) was used in flow cytometry on human samples . Am J Transplant (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; tbl s1
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (tbl s1). PLoS ONE (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 9a
In order to explore a macrophage TLR9-BTK-calcineurin-NFAT signaling pathway involved in impair fungal immunity, BioLegend HLA-DRB1 antibody (Biolegend, 307617) was used in flow cytometry on human samples (fig 9a). EMBO Mol Med (2015) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; 15 ug/ml; fig 4
BioLegend HLA-DRB1 antibody (BioLegend, L432) was used in blocking or activating experiments on human samples at 15 ug/ml (fig 4). Vaccine (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BioLegend HLA-DRB1 antibody (BioLegend, clone L243) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 3
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples (fig 3). Nephrol Dial Transplant (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . Eur J Immunol (2015) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to identify the role of GammaDelta T cells in acute HIV infection, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in flow cytometry on human samples . J Leukoc Biol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; fig 1
In order to study the role of plasmacytoid dendritic cells in human immunodeficiency virus type 1 infection and pathogenesis, BioLegend HLA-DRB1 antibody (Biolegend, 307604) was used in flow cytometry on human samples (fig 1). PLoS Pathog (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
mouse monoclonal (L243)
  • flow cytometry; human; loading ...; fig 6b
BioLegend HLA-DRB1 antibody (Biolegend, L243) was used in flow cytometry on human samples (fig 6b). J Immunol (2014) ncbi
mouse monoclonal (L243)
In order to investigate the progression of innate responses to mycobacteria in infants, BioLegend HLA-DRB1 antibody (Biolegend, L243) was used . J Immunol (2014) ncbi
mouse monoclonal (L243)
  • blocking or activating experiments; human; loading ...; fig 5A
In order to investigate human T lymphotropic virus type 1 bZIP factor-specific CD4 T cell responses, BioLegend HLA-DRB1 antibody (BioLegend, L243) was used in blocking or activating experiments on human samples (fig 5A). J Immunol (2014) ncbi
Invitrogen
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig st12
In order to identify new types of human blood dendritic cells, monocytes, and progenitors through single-cell RNA-seq, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig st12). Science (2017) ncbi
mouse monoclonal (MEM-267)
  • western blot; human; loading ...; fig 3d
In order to report the effects of long-term lipopolysaccharide exposure on monocytes, Invitrogen HLA-DRB1 antibody (Thermo Fischer Scientific, MA1-19393) was used in western blot on human samples (fig 3d). Toxicol In Vitro (2017) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 5a
In order to use CRISPR/Cas9 editing to generate reagents to study the role of IRF8 in human hematopoiesis, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 5a). Stem Cells (2017) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 4a
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 4a). PLoS ONE (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen HLA-DRB1 antibody (Invitrogen, MHLDR31) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
rat monoclonal (YD1/63.4.10)
  • flow cytometry; human; loading ...; fig 4b
In order to assess dextran-based nanoparticles as a drug delivery system to target myeloid cells of the liver, Invitrogen HLA-DRB1 antibody (Thermo Fisher, MA1-70113) was used in flow cytometry on human samples (fig 4b). Nanomedicine (Lond) (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 2f
In order to study the cytolytic effector capacity of HIV-specific CD8+ T cells, Invitrogen HLA-DRB1 antibody (Invitrogen, LN3) was used in flow cytometry on human samples (fig 2f). PLoS Pathog (2016) ncbi
rat monoclonal (YE2/36 HLK)
  • immunohistochemistry - paraffin section; human; 1:50; fig 4
In order to analyze the correlation between severity of allograft rejection and outcome in human kidney transplantation and infiltration of macrophages, Invitrogen HLA-DRB1 antibody (ThermoScientific, MA1-70112) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 4). PLoS ONE (2016) ncbi
mouse monoclonal (CR3/43)
  • immunohistochemistry - paraffin section; human; 1:1000; fig st2
In order to characterize intratumoral immune response and CD103 in breast cancer, Invitrogen HLA-DRB1 antibody (Affinity Bioreagents, CR3/43) was used in immunohistochemistry - paraffin section on human samples at 1:1000 (fig st2). Clin Cancer Res (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; tbl 2
In order to determine the contribution of Leukocyte Ig Like Receptors to Mycobacterium tuberculosis infection, Invitrogen HLA-DRB1 antibody (Invitrogen, VXMHLDR17) was used in flow cytometry on human samples (tbl 2). Sci Rep (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; African green monkey; loading ...
In order to report that B cells modulate the local granulomatous response in Mycobacterium tuberculosis-infected macaques during acute infection, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on African green monkey samples . Infect Immun (2016) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 1
In order to characterize the gut-associated lymphoid tissue of HIV-controllers, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 1). Immunol Res (2016) ncbi
mouse monoclonal (TU36)
  • flow cytometry; rhesus macaque; fig 5
In order to characterize functional and phenotypic properties of monoclonal antibodies specific for Rhesus Macaque CD200, Mincle, and CD200R, Invitrogen HLA-DRB1 antibody (Life Technologies, MHLDR17) was used in flow cytometry on rhesus macaque samples (fig 5). PLoS ONE (2015) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; 5:100; fig s3
In order to show that hepatitis B virus exposure in utero enhances immunity to bacterial infections, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples at 5:100 (fig s3). Nat Commun (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the role of melanoma cell surface-associated calreticulin in melphalan-induced antitumor immunity, Invitrogen HLA-DRB1 antibody (BD, MHLDR01) was used in flow cytometry on human samples . Cancer Res (2015) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the role of autophagy in melanoma, Invitrogen HLA-DRB1 antibody (Life Technologies, MHLDR01) was used in flow cytometry on human samples . Biochem Pharmacol (2015) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; human; 1:100; fig 2
In order to discuss a meta-analysis of genome-wide association study data on Abeta1-42 and pTau181 in Alzheimer's disease dementia patients, Invitrogen HLA-DRB1 antibody (Thermo, MA1-35420) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 2). Hum Mol Genet (2014) ncbi
mouse monoclonal (CR3/43)
  • immunohistochemistry; human; tbl 1
In order to study the recognition of tumor mutations by T-cells during the transition from primary to recurrent ovarian cancer, Invitrogen HLA-DRB1 antibody (Affinity Bioreagents, MAI-25914) was used in immunohistochemistry on human samples (tbl 1). Clin Cancer Res (2014) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:20; fig s6
In order to decipher how susequent acute infection is supressed in T cell responses after exposure to subinfectious hepatitis C virus, Invitrogen HLA-DRB1 antibody (Invitrogen, Tu36) was used in flow cytometry on human samples at 1:20 (fig s6). Nat Med (2013) ncbi
mouse monoclonal (LN-3)
  • flow cytometry; human; loading ...; fig 3b
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, Invitrogen HLA-DRB1 antibody (eBioscience, LN3) was used in flow cytometry on human samples (fig 3b). J Infect Dis (2014) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen HLA-DRB1 antibody (Caltag Laboratories, clone Tu36) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:50; fig 2
In order to optimize rhesus monkey decellularized kidney scaffolds, Invitrogen HLA-DRB1 antibody (Life Technologies, LN3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:50 (fig 2). PLoS ONE (2013) ncbi
mouse monoclonal (TU36)
  • flow cytometry; rhesus macaque; loading ...; fig 2a
In order to test if vaccination alters the activation state of T cells within the gastrointestinal mucosa, inguinal lymph nodes, and peripheral blood, Invitrogen HLA-DRB1 antibody (Invitrogen, TU36) was used in flow cytometry on rhesus macaque samples (fig 2a). Hum Vaccin Immunother (2012) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study the diverse functions of li in DCs, Invitrogen HLA-DRB1 antibody (Caltag Laboratories, MHLDR05) was used in flow cytometry on human samples . J Leukoc Biol (2012) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - paraffin section; rhesus macaque; 1:200; tbl 2
  • flow cytometry; rhesus macaque; fig 7
In order to study the host inflammatory granulomatous response that controls cutaneous leishmaniasis using a macaque model, Invitrogen HLA-DRB1 antibody (Zymed Laboratory, clone LN-3) was used in immunohistochemistry - paraffin section on rhesus macaque samples at 1:200 (tbl 2) and in flow cytometry on rhesus macaque samples (fig 7). J Pathol (2008) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; 1:50
In order to describe a culture method for directed differentiation of human embryonic stem cells to dendritic cells, Invitrogen HLA-DRB1 antibody (Caltag, MHLDR04) was used in flow cytometry on human samples at 1:50. Methods Mol Biol (2007) ncbi
mouse monoclonal (TU36)
  • immunohistochemistry; human; fig 2
In order to characterize the frequency of potential targets of HIV infection within the female reproductive tract, Invitrogen HLA-DRB1 antibody (Caltag, MHLDR01) was used in immunohistochemistry on human samples (fig 2). Immunology (2004) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study CD45 splice variants in patients with hemophagocytic lymphohistiocytosis, Invitrogen HLA-DRB1 antibody (Caltag, TU36) was used in flow cytometry on human samples . Pediatr Res (2004) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to test if CD103 has a regulatory role in the microenvironment of the epithelial cell layer, Invitrogen HLA-DRB1 antibody (Caltag, TU36) was used in flow cytometry on human samples . Cytometry B Clin Cytom (2003) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human; fig 4
In order to report that CD34(+) progenitor cell-derived Langerhans cells-type DCs exhibit a differentiation state-dependent susceptibility to CMV infection, Invitrogen HLA-DRB1 antibody (Caltag, TU36) was used in flow cytometry on human samples (fig 4). J Virol (2003) ncbi
mouse monoclonal (LN-3)
  • immunohistochemistry - frozen section; human; fig 6
  • flow cytometry; human; fig 4
In order to determine the expression of a human macrophage lectin specific for galactose/N-acetylgalactosamine during macrophage differentiation, Invitrogen HLA-DRB1 antibody (Zymed, LN-3) was used in immunohistochemistry - frozen section on human samples (fig 6) and in flow cytometry on human samples (fig 4). Int Immunol (2002) ncbi
mouse monoclonal (HL-38)
  • flow cytometry; human; 4 ug/ml
In order to characterize human splenic dendritic cells, Invitrogen HLA-DRB1 antibody (Caltag, HL38) was used in flow cytometry on human samples at 4 ug/ml. Blood (2001) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to study perturbations in eosinophil homeostasis following treatment of lymphatic filariasis, Invitrogen HLA-DRB1 antibody (Caltag, TU 36) was used in flow cytometry on human samples . Infect Immun (2000) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to report that the expression of CD41 and c-mpl were not predictive of commitment to the megakaryocyte lineage, Invitrogen HLA-DRB1 antibody (Caltag, TU36) was used in flow cytometry on human samples . Br J Haematol (1999) ncbi
mouse monoclonal (TU36)
  • flow cytometry; human
In order to determine the number of CD4, CCR5, and CXCR4 antibody-binding sites on various T cells and macrophages, Invitrogen HLA-DRB1 antibody (Caltag, TU36) was used in flow cytometry on human samples . Proc Natl Acad Sci U S A (1999) ncbi
mouse monoclonal (HL-38)
  • flow cytometry; human; fig 3
In order to test if recombinant human interferon-gamma enhancing clearance of microbes in patients with chronic granulomatous disease, Invitrogen HLA-DRB1 antibody (Caltag, HL38) was used in flow cytometry on human samples (fig 3). Blood (1997) ncbi
mouse monoclonal (HL-38)
  • flow cytometry; human
In order to describe the cellular changes that IFN beta-1b treatment induced in the experimental autoimmune encephalomyelitis model, Invitrogen HLA-DRB1 antibody (Caltag, HL38) was used in flow cytometry on human samples . J Clin Invest (1997) ncbi
Miltenyi Biotec
mouse monoclonal (AC122)
  • flow cytometry; human; loading ...; fig 4c
Miltenyi Biotec HLA-DRB1 antibody (Miltenyi Biotec, AC122) was used in flow cytometry on human samples (fig 4c). Cell Death Dis (2019) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig s3j
Miltenyi Biotec HLA-DRB1 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig s3j). Biol Blood Marrow Transplant (2018) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig st1
Miltenyi Biotec HLA-DRB1 antibody (Miltenyi, REA332) was used in flow cytometry on human samples (fig st1). Front Immunol (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; 1:20; loading ...; fig 6a
Miltenyi Biotec HLA-DRB1 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples at 1:20 (fig 6a). J Immunol (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a recombinant Saccharomyces cerevisiae as a vehicle to deliver genes to primary human macrophages, Miltenyi Biotec HLA-DRB1 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1a). Eur J Pharm Biopharm (2017) ncbi
human monoclonal (REA332)
  • flow cytometry; human; fig 1
In order to analyze how Saccharomyces cerevisiae interacts with different macrophage subsets, Miltenyi Biotec HLA-DRB1 antibody (Miltenyi Biotec, REA332) was used in flow cytometry on human samples (fig 1). Inflammation (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (L243)
  • flow cytometry; human; 1:50; fig 1
Santa Cruz Biotechnology HLA-DRB1 antibody (Santa Cruz, sc-18875) was used in flow cytometry on human samples at 1:50 (fig 1). Stem Cell Res Ther (2016) ncbi
mouse monoclonal (ML11C11)
  • immunohistochemistry - paraffin section; human; 1:50; fig 1
Santa Cruz Biotechnology HLA-DRB1 antibody (santa Cruz, sc-73366) was used in immunohistochemistry - paraffin section on human samples at 1:50 (fig 1). PLoS ONE (2016) ncbi
mouse monoclonal (TAL 14.1)
  • immunoprecipitation; mouse
In order to assess the impact of the different HLA-DR15 haplotype alleles on disease susceptibility in a new humanized multiple sclerosis model, Santa Cruz Biotechnology HLA-DRB1 antibody (Santa Cruz Biotechnology, TAL 14.1) was used in immunoprecipitation on mouse samples . J Biol Chem (2015) ncbi
Articles Reviewed
  1. Park J, Botting R, Domínguez Conde C, Popescu D, Lavaert M, Kunz D, et al. A cell atlas of human thymic development defines T cell repertoire formation. Science. 2020;367: pubmed publisher
  2. Uhlen M, Karlsson M, Zhong W, Tebani A, Pou C, Mikes J, et al. A genome-wide transcriptomic analysis of protein-coding genes in human blood cells. Science. 2019;366: pubmed publisher
  3. Stewart B, Ferdinand J, Young M, Mitchell T, Loudon K, Riding A, et al. Spatiotemporal immune zonation of the human kidney. Science. 2019;365:1461-1466 pubmed publisher
  4. Martin J, Chang C, Boschetti G, Ungaro R, Giri M, Grout J, et al. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy. Cell. 2019;178:1493-1508.e20 pubmed publisher
  5. Dumont A, de Rosny C, Kieu T, Perrey S, Berger H, Fluckiger A, et al. Docosahexaenoic acid inhibits both NLRP3 inflammasome assembly and JNK-mediated mature IL-1β secretion in 5-fluorouracil-treated MDSC: implication in cancer treatment. Cell Death Dis. 2019;10:485 pubmed publisher
  6. Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck W, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;: pubmed publisher
  7. Zhang J, Supakorndej T, Krambs J, Rao M, Abou Ezzi G, Ye R, et al. Bone marrow dendritic cells regulate hematopoietic stem/progenitor cell trafficking. J Clin Invest. 2019;129:2920-2931 pubmed publisher
  8. Terahara K, Iwabuchi R, Hosokawa M, Nishikawa Y, Takeyama H, Takahashi Y, et al. A CCR5+ memory subset within HIV-1-infected primary resting CD4+ T cells is permissive for replication-competent, latently infected viruses in vitro. BMC Res Notes. 2019;12:242 pubmed publisher
  9. Wagner J, Rapsomaniki M, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, et al. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell. 2019;177:1330-1345.e18 pubmed publisher
  10. Sweere J, Van Belleghem J, Ishak H, Bach M, Popescu M, Sunkari V, et al. Bacteriophage trigger antiviral immunity and prevent clearance of bacterial infection. Science. 2019;363: pubmed publisher
  11. Chakarov S, Lim H, Tan L, Lim S, See P, Lum J, et al. Two distinct interstitial macrophage populations coexist across tissues in specific subtissular niches. Science. 2019;363: pubmed publisher
  12. Crippa S, Rossella V, Aprile A, Silvestri L, Rivis S, Scaramuzza S, et al. Bone marrow stromal cells from β-thalassemia patients have impaired hematopoietic supportive capacity. J Clin Invest. 2019;129:1566-1580 pubmed publisher
  13. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  14. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  15. Jones G, Bain C, Fenton T, Kelly A, Brown S, Ivens A, et al. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front Immunol. 2018;9:2764 pubmed publisher
  16. Ding L, Kim H, Wang Q, Kearns M, Jiang T, Ohlson C, et al. PARP Inhibition Elicits STING-Dependent Antitumor Immunity in Brca1-Deficient Ovarian Cancer. Cell Rep. 2018;25:2972-2980.e5 pubmed publisher
  17. Poncette L, Chen X, Lorenz F, Blankenstein T. Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression. J Clin Invest. 2019;129:324-335 pubmed publisher
  18. Kelly A, Günaltay S, McEntee C, Shuttleworth E, Smedley C, Houston S, et al. Human monocytes and macrophages regulate immune tolerance via integrin αvβ8-mediated TGFβ activation. J Exp Med. 2018;215:2725-2736 pubmed publisher
  19. Otsuka Y, Watanabe E, Shinya E, Okura S, Saeki H, Geijtenbeek T, et al. Differentiation of Langerhans Cells from Monocytes and Their Specific Function in Inducing IL-22-Specific Th Cells. J Immunol. 2018;201:3006-3016 pubmed publisher
  20. Olin A, Henckel E, Chen Y, Lakshmikanth T, Pou C, Mikes J, et al. Stereotypic Immune System Development in Newborn Children. Cell. 2018;174:1277-1292.e14 pubmed publisher
  21. Kong X, Martinez Barricarte R, Kennedy J, Mele F, Lazarov T, Deenick E, et al. Disruption of an antimycobacterial circuit between dendritic and helper T cells in human SPPL2a deficiency. Nat Immunol. 2018;19:973-985 pubmed publisher
  22. Walwyn Brown K, Guldevall K, Saeed M, Pende D, Önfelt B, MacDonald A, et al. Human NK Cells Lyse Th2-Polarizing Dendritic Cells via NKp30 and DNAM-1. J Immunol. 2018;201:2028-2041 pubmed publisher
  23. Arnold I, Artola Borán M, Tallón de Lara P, Kyburz A, Taube C, OTTEMANN K, et al. Eosinophils suppress Th1 responses and restrict bacterially induced gastrointestinal inflammation. J Exp Med. 2018;215:2055-2072 pubmed publisher
  24. Alissafi T, Hatzioannou A, Mintzas K, Barouni R, Banos A, Sormendi S, et al. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells. J Clin Invest. 2018;128:3840-3852 pubmed publisher
  25. Dumbovic G, Biayna J, Banús J, Samuelsson J, Roth A, Diederichs S, et al. A novel long non-coding RNA from NBL2 pericentromeric macrosatellite forms a perinucleolar aggregate structure in colon cancer. Nucleic Acids Res. 2018;46:5504-5524 pubmed publisher
  26. Fan X, Guo D, Cheung A, Poon Z, Yap C, Goh S, et al. Mesenchymal Stromal Cell (MSC)-Derived Combination of CXCL5 and Anti-CCL24 Is Synergistic and Superior to MSC and Cyclosporine for the Treatment of Graft-versus-Host Disease. Biol Blood Marrow Transplant. 2018;24:1971-1980 pubmed publisher
  27. Zacharakis N, Chinnasamy H, Black M, Xu H, Lu Y, Zheng Z, et al. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer. Nat Med. 2018;24:724-730 pubmed publisher
  28. Melo Gonzalez F, Fenton T, Forss C, Smedley C, Goenka A, MacDonald A, et al. Intestinal mucin activates human dendritic cells and IL-8 production in a glycan-specific manner. J Biol Chem. 2018;293:8543-8553 pubmed publisher
  29. Li M, Zhang W, Liu J, Li M, Zhang Y, Xiong Y, et al. Dynamic changes in the immunological characteristics of T lymphocytes in surviving patients with severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2018;70:72-80 pubmed publisher
  30. Liu R, Merola J, Manes T, Qin L, Tietjen G, Lopez Giraldez F, et al. Interferon-γ converts human microvascular pericytes into negative regulators of alloimmunity through induction of indoleamine 2,3-dioxygenase 1. JCI Insight. 2018;3: pubmed publisher
  31. Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, et al. Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines. Oncol Lett. 2018;15:509-514 pubmed publisher
  32. Bujko A, Atlasy N, Landsverk O, Richter L, Yaqub S, Horneland R, et al. Transcriptional and functional profiling defines human small intestinal macrophage subsets. J Exp Med. 2018;215:441-458 pubmed publisher
  33. Delso Vallejo M, Kollet J, Koehl U, Huppert V. Influence of Irradiated Peripheral Blood Mononuclear Cells on Both Ex Vivo Proliferation of Human Natural Killer Cells and Change in Cellular Property. Front Immunol. 2017;8:854 pubmed publisher
  34. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  35. Gosselin D, Skola D, Coufal N, Holtman I, Schlachetzki J, Sajti E, et al. An environment-dependent transcriptional network specifies human microglia identity. Science. 2017;356: pubmed publisher
  36. Chevrier S, Levine J, Zanotelli V, Silina K, Schulz D, Bacac M, et al. An Immune Atlas of Clear Cell Renal Cell Carcinoma. Cell. 2017;169:736-749.e18 pubmed publisher
  37. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  38. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  39. Villani A, Satija R, Reynolds G, Sarkizova S, Shekhar K, Fletcher J, et al. Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors. Science. 2017;356: pubmed publisher
  40. Zhang J, Xu X, Shi M, Chen Y, Yu D, Zhao C, et al. CD13hi Neutrophil-like myeloid-derived suppressor cells exert immune suppression through Arginase 1 expression in pancreatic ductal adenocarcinoma. Oncoimmunology. 2017;6:e1258504 pubmed publisher
  41. Borriello F, Iannone R, Di Somma S, Vastolo V, Petrosino G, Visconte F, et al. Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes. J Immunol. 2017;198:3426-3435 pubmed publisher
  42. Mytych J, Romerowicz Misielak M, Koziorowski M. Long-term culture with lipopolysaccharide induces dose-dependent cytostatic and cytotoxic effects in THP-1 monocytes. Toxicol In Vitro. 2017;42:1-9 pubmed publisher
  43. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed publisher
  44. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  45. O CONNOR D, Clutterbuck E, Thompson A, Snape M, Ramasamy M, Kelly D, et al. High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine. Genome Med. 2017;9:11 pubmed publisher
  46. Sontag S, Förster M, Qin J, Wanek P, Mitzka S, Schüler H, et al. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells. Stem Cells. 2017;35:898-908 pubmed publisher
  47. Cheng L, Ma J, Li J, Li D, Li G, Li F, et al. Blocking type I interferon signaling enhances T cell recovery and reduces HIV-1 reservoirs. J Clin Invest. 2017;127:269-279 pubmed publisher
  48. Kasturi S, Kozlowski P, Nakaya H, Burger M, Russo P, Pham M, et al. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques. J Virol. 2017;91: pubmed publisher
  49. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  50. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  51. Sumatoh H, Teng K, Cheng Y, Newell E. Optimization of mass cytometry sample cryopreservation after staining. Cytometry A. 2017;91:48-61 pubmed publisher
  52. Misra S, Selvam A, Wallenberg M, Ambati A, Matolcsy A, Magalhaes I, et al. Selenite promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells. Oncotarget. 2016;7:74686-74700 pubmed publisher
  53. Wang Y, Ma C, Ling Y, Bousfiha A, Camcioglu Y, Jacquot S, et al. Dual T cell- and B cell-intrinsic deficiency in humans with biallelic RLTPR mutations. J Exp Med. 2016;213:2413-2435 pubmed
  54. Foerster F, Bamberger D, Schupp J, Weilbächer M, Kaps L, Strobl S, et al. Dextran-based therapeutic nanoparticles for hepatic drug delivery. Nanomedicine (Lond). 2016;11:2663-2677 pubmed
  55. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  56. Greco S, Torres Hernandez A, Kalabin A, Whiteman C, Rokosh R, Ravirala S, et al. Mincle Signaling Promotes Con A Hepatitis. J Immunol. 2016;197:2816-27 pubmed publisher
  57. van Erp F, Knol E, Pontoppidan B, Meijer Y, van der Ent C, Knulst A. The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. J Allergy Clin Immunol. 2017;139:358-360.e8 pubmed publisher
  58. Xing Y, Cao R, Hu H. TLR and NLRP3 inflammasome-dependent innate immune responses to tumor-derived autophagosomes (DRibbles). Cell Death Dis. 2016;7:e2322 pubmed publisher
  59. Demers K, Makedonas G, Buggert M, Eller M, Ratcliffe S, Goonetilleke N, et al. Temporal Dynamics of CD8+ T Cell Effector Responses during Primary HIV Infection. PLoS Pathog. 2016;12:e1005805 pubmed publisher
  60. Cerny D, Thi Le D, The T, Zuest R, Kg S, Velumani S, et al. Complete human CD1a deficiency on Langerhans cells due to a rare point mutation in the coding sequence. J Allergy Clin Immunol. 2016;138:1709-1712.e11 pubmed publisher
  61. Rölle A, Halenius A, Ewen E, Cerwenka A, Hengel H, Momburg F. CD2-CD58 interactions are pivotal for the activation and function of adaptive natural killer cells in human cytomegalovirus infection. Eur J Immunol. 2016;46:2420-2425 pubmed publisher
  62. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed publisher
  63. Wittmann A, Lamprinaki D, Bowles K, Katzenellenbogen E, Knirel Y, Whitfield C, et al. Dectin-2 Recognizes Mannosylated O-antigens of Human Opportunistic Pathogens and Augments Lipopolysaccharide Activation of Myeloid Cells. J Biol Chem. 2016;291:17629-38 pubmed publisher
  64. Booth J, Duggan E, Patel V, Langer M, Wu W, Braun A, et al. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models. Microbes Infect. 2016;18:615-626 pubmed publisher
  65. Gadd V, Patel P, Jose S, Horsfall L, Powell E, Irvine K. Altered Peripheral Blood Monocyte Phenotype and Function in Chronic Liver Disease: Implications for Hepatic Recruitment and Systemic Inflammation. PLoS ONE. 2016;11:e0157771 pubmed publisher
  66. Tomasello L, Musso R, Cillino G, Pitrone M, Pizzolanti G, Coppola A, et al. Donor age and long-term culture do not negatively influence the stem potential of limbal fibroblast-like stem cells. Stem Cell Res Ther. 2016;7:83 pubmed publisher
  67. Bergler T, Jung B, Bourier F, Kühne L, Banas M, Rümmele P, et al. Infiltration of Macrophages Correlates with Severity of Allograft Rejection and Outcome in Human Kidney Transplantation. PLoS ONE. 2016;11:e0156900 pubmed publisher
  68. Zanetti S, Ziblat A, Torres N, Zwirner N, Bouzat C. Expression and Functional Role of ?7 Nicotinic Receptor in Human Cytokine-stimulated Natural Killer (NK) Cells. J Biol Chem. 2016;291:16541-52 pubmed publisher
  69. Wang Z, Milne K, Derocher H, Webb J, Nelson B, Watson P. CD103 and Intratumoral Immune Response in Breast Cancer. Clin Cancer Res. 2016;22:6290-6297 pubmed
  70. Rai V, Rao V, Shao Z, Agrawal D. Dendritic Cells Expressing Triggering Receptor Expressed on Myeloid Cells-1 Correlate with Plaque Stability in Symptomatic and Asymptomatic Patients with Carotid Stenosis. PLoS ONE. 2016;11:e0154802 pubmed publisher
  71. Ruibal P, Oestereich L, Lüdtke A, Becker Ziaja B, Wozniak D, Kerber R, et al. Unique human immune signature of Ebola virus disease in Guinea. Nature. 2016;533:100-4 pubmed publisher
  72. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  73. Zwang N, Zhang R, Germana S, Fan M, Hastings W, Cao A, et al. Selective Sparing of Human Tregs by Pharmacologic Inhibitors of the Phosphatidylinositol 3-Kinase and MEK Pathways. Am J Transplant. 2016;16:2624-38 pubmed publisher
  74. Leone D, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler A, et al. The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury. PLoS ONE. 2016;11:e0151674 pubmed publisher
  75. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  76. Zondler L, Müller K, Khalaji S, Bliederhäuser C, Ruf W, Grozdanov V, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391-411 pubmed publisher
  77. Hogan L, Jones D, Allen R. Expression of the innate immune receptor LILRB5 on monocytes is associated with mycobacteria exposure. Sci Rep. 2016;6:21780 pubmed publisher
  78. Phuah J, Wong E, Gideon H, Maiello P, Coleman M, Hendricks M, et al. Effects of B Cell Depletion on Early Mycobacterium tuberculosis Infection in Cynomolgus Macaques. Infect Immun. 2016;84:1301-1311 pubmed publisher
  79. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
  80. Johnson D, Estrada M, Salgado R, Sanchez V, Doxie D, Opalenik S, et al. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy. Nat Commun. 2016;7:10582 pubmed publisher
  81. Kanderová V, Kuzilkova D, Stuchly J, Vaskova M, Brdicka T, Fiser K, et al. High-resolution Antibody Array Analysis of Childhood Acute Leukemia Cells. Mol Cell Proteomics. 2016;15:1246-61 pubmed publisher
  82. Younis R, Han K, Webb T. Human Head and Neck Squamous Cell Carcinoma-Associated Semaphorin 4D Induces Expansion of Myeloid-Derived Suppressor Cells. J Immunol. 2016;196:1419-29 pubmed publisher
  83. Gonzalez S, Taborda N, Correa L, Castro G, Hernandez J, Montoya C, et al. Particular activation phenotype of T cells expressing HLA-DR but not CD38 in GALT from HIV-controllers is associated with immune regulation and delayed progression to AIDS. Immunol Res. 2016;64:765-74 pubmed publisher
  84. Byrareddy S, Little D, Mayne A, Villinger F, Ansari A. Phenotypic and Functional Characterization of Monoclonal Antibodies with Specificity for Rhesus Macaque CD200, CD200R and Mincle. PLoS ONE. 2015;10:e0140689 pubmed publisher
  85. Schulz A, Mälzer J, Domingo C, Jürchott K, Grützkau A, Babel N, et al. Low Thymic Activity and Dendritic Cell Numbers Are Associated with the Immune Response to Primary Viral Infection in Elderly Humans. J Immunol. 2015;195:4699-711 pubmed publisher
  86. McCausland M, Juchnowski S, Zidar D, Kuritzkes D, Andrade A, Sieg S, et al. Altered Monocyte Phenotype in HIV-1 Infection Tends to Normalize with Integrase-Inhibitor-Based Antiretroviral Therapy. PLoS ONE. 2015;10:e0139474 pubmed publisher
  87. Rosario M, Liu B, Kong L, Collins L, Schneider S, Chen X, et al. The IL-15-Based ALT-803 Complex Enhances FcγRIIIa-Triggered NK Cell Responses and In Vivo Clearance of B Cell Lymphomas. Clin Cancer Res. 2016;22:596-608 pubmed publisher
  88. Frederiksen J, Buggert M, Noyan K, Nowak P, Sönnerborg A, Lund O, et al. Multidimensional Clusters of CD4+ T Cell Dysfunction Are Primarily Associated with the CD4/CD8 Ratio in Chronic HIV Infection. PLoS ONE. 2015;10:e0137635 pubmed publisher
  89. Denkovskij J, Rudys R, Bernotiene E, Minderis M, Bagdonas S, Kirdaite G. Cell surface markers and exogenously induced PpIX in synovial mesenchymal stem cells. Cytometry A. 2015;87:1001-11 pubmed publisher
  90. Li X, Liu X, Zhao Y, Zhong R, Song A, Sun L. Effect of thymosin α₁ on the phenotypic and functional maturation of dendritic cells from children with acute lymphoblastic leukemia. Mol Med Rep. 2015;12:6093-7 pubmed publisher
  91. Pojero F, Flores Montero J, Sanoja L, Pérez J, Puig N, Paiva B, et al. Utility of CD54, CD229, and CD319 for the identification of plasma cells in patients with clonal plasma cell diseases. Cytometry B Clin Cytom. 2016;90:91-100 pubmed publisher
  92. Yawata N, Selva K, Liu Y, Tan K, Lee A, Siak J, et al. Dynamic change in natural killer cell type in the human ocular mucosa in situ as means of immune evasion by adenovirus infection. Mucosal Immunol. 2016;9:159-70 pubmed publisher
  93. Kaushansky N, Eisenstein M, Boura Halfon S, Hansen B, Nielsen C, Milo R, et al. Role of a Novel Human Leukocyte Antigen-DQA1*01:02;DRB1*15:01 Mixed Isotype Heterodimer in the Pathogenesis of "Humanized" Multiple Sclerosis-like Disease. J Biol Chem. 2015;290:15260-78 pubmed publisher
  94. Thomas K, Valenzuela N, Gjertson D, Mulder A, Fishbein M, Parry G, et al. An Anti-C1s Monoclonal, TNT003, Inhibits Complement Activation Induced by Antibodies Against HLA. Am J Transplant. 2015;15:2037-49 pubmed publisher
  95. Weinberg A, Muresan P, Richardson K, Fenton T, Domínguez T, Bloom A, et al. Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine. PLoS ONE. 2015;10:e0122431 pubmed publisher
  96. Hong M, Sandalova E, Low D, Gehring A, Fieni S, Amadei B, et al. Trained immunity in newborn infants of HBV-infected mothers. Nat Commun. 2015;6:6588 pubmed publisher
  97. Dudek Perić A, Ferreira G, Muchowicz A, Wouters J, Prada N, Martin S, et al. Antitumor immunity triggered by melphalan is potentiated by melanoma cell surface-associated calreticulin. Cancer Res. 2015;75:1603-14 pubmed publisher
  98. Herbst S, Shah A, Mazon Moya M, Marzola V, Jensen B, Reed A, et al. Phagocytosis-dependent activation of a TLR9-BTK-calcineurin-NFAT pathway co-ordinates innate immunity to Aspergillus fumigatus. EMBO Mol Med. 2015;7:240-58 pubmed publisher
  99. Tomimaru Y, Mishra S, Safran H, Charpentier K, Martin W, De Groot A, et al. Aspartate-β-hydroxylase induces epitope-specific T cell responses in hepatocellular carcinoma. Vaccine. 2015;33:1256-66 pubmed publisher
  100. Martin S, Dudek Perić A, Maes H, Garg A, Gabrysiak M, Demirsoy S, et al. Concurrent MEK and autophagy inhibition is required to restore cell death associated danger-signalling in Vemurafenib-resistant melanoma cells. Biochem Pharmacol. 2015;93:290-304 pubmed publisher
  101. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  102. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  103. Rogacev K, Zawada A, Hundsdorfer J, Achenbach M, Held G, Fliser D, et al. Immunosuppression and monocyte subsets. Nephrol Dial Transplant. 2015;30:143-53 pubmed publisher
  104. Ziblat A, Domaica C, Spallanzani R, Iraolagoitia X, Rossi L, Avila D, et al. IL-27 stimulates human NK-cell effector functions and primes NK cells for IL-18 responsiveness. Eur J Immunol. 2015;45:192-202 pubmed publisher
  105. Li Z, Li W, Li N, Jiao Y, Chen D, Cui L, et al. γδ T cells are involved in acute HIV infection and associated with AIDS progression. PLoS ONE. 2014;9:e106064 pubmed publisher
  106. Chao Y, Kaliaperumal N, Chretien A, Tang S, Lee B, Poidinger M, et al. Human plasmacytoid dendritic cells regulate IFN-α production through activation-induced splicing of IL-18Rα. J Leukoc Biol. 2014;96:1037-46 pubmed publisher
  107. Li G, Cheng M, Nunoya J, Cheng L, Guo H, Yu H, et al. Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice. PLoS Pathog. 2014;10:e1004291 pubmed publisher
  108. Ramirez A, van der Flier W, Herold C, Ramonet D, Heilmann S, Lewczuk P, et al. SUCLG2 identified as both a determinator of CSF A?1-42 levels and an attenuator of cognitive decline in Alzheimer's disease. Hum Mol Genet. 2014;23:6644-58 pubmed publisher
  109. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  110. Klinker M, Lizzio V, Reed T, Fox D, Lundy S. Human B Cell-Derived Lymphoblastoid Cell Lines Constitutively Produce Fas Ligand and Secrete MHCII(+)FasL(+) Killer Exosomes. Front Immunol. 2014;5:144 pubmed publisher
  111. Fredriksson K, Mishra A, Lam J, Mushaben E, Cuento R, Meyer K, et al. The very low density lipoprotein receptor attenuates house dust mite-induced airway inflammation by suppressing dendritic cell-mediated adaptive immune responses. J Immunol. 2014;192:4497-509 pubmed publisher
  112. Shey M, Nemes E, Whatney W, de Kock M, Africa H, Barnard C, et al. Maturation of innate responses to mycobacteria over the first nine months of life. J Immunol. 2014;192:4833-43 pubmed publisher
  113. Narita T, Ishida T, Masaki A, Suzuki S, Ito A, Mori F, et al. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation. J Immunol. 2014;192:940-7 pubmed publisher
  114. Wick D, Webb J, Nielsen J, Martin S, Kroeger D, Milne K, et al. Surveillance of the tumor mutanome by T cells during progression from primary to recurrent ovarian cancer. Clin Cancer Res. 2014;20:1125-34 pubmed publisher
  115. Park S, Veerapu N, Shin E, Biancotto A, McCoy J, Capone S, et al. Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection. Nat Med. 2013;19:1638-42 pubmed publisher
  116. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  117. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed publisher
  118. Nakayama K, Lee C, Batchelder C, Tarantal A. Tissue specificity of decellularized rhesus monkey kidney and lung scaffolds. PLoS ONE. 2013;8:e64134 pubmed publisher
  119. Reuter M, Yuan S, Marx P, Kutzler M, Weiner D, Betts M. DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells. Hum Vaccin Immunother. 2012;8:1648-53 pubmed publisher
  120. Landsverk O, Ottesen A, Berg Larsen A, Appel S, Bakke O. Differential regulation of MHC II and invariant chain expression during maturation of monocyte-derived dendritic cells. J Leukoc Biol. 2012;91:729-37 pubmed publisher
  121. Souza Lemos C, de Campos S, Teva A, Corte Real S, Fonseca E, Porrozzi R, et al. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375-86 pubmed publisher
  122. Vodyanik M, Slukvin I. Directed differentiation of human embryonic stem cells to dendritic cells. Methods Mol Biol. 2007;407:275-93 pubmed publisher
  123. Yeaman G, Asin S, Weldon S, Demian D, Collins J, Gonzalez J, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology. 2004;113:524-33 pubmed
  124. Boxall S, McCormick J, Beverley P, Strobel S, De Filippi P, Dawes R, et al. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis. Pediatr Res. 2004;55:478-84 pubmed
  125. Braun R, Foerster M, Grahmann P, Haefner D, Workalemahu G, Kroegel C. Phenotypic and molecular characterization of CD103+ CD4+ T cells in bronchoalveolar lavage from patients with interstitial lung diseases. Cytometry B Clin Cytom. 2003;54:19-27 pubmed
  126. Hertel L, Lacaille V, Strobl H, Mellins E, Mocarski E. Susceptibility of immature and mature Langerhans cell-type dendritic cells to infection and immunomodulation by human cytomegalovirus. J Virol. 2003;77:7563-74 pubmed
  127. Higashi N, Morikawa A, Fujioka K, Fujita Y, Sano Y, Miyata Takeuchi M, et al. Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages. Int Immunol. 2002;14:545-54 pubmed
  128. McIlroy D, Troadec C, Grassi F, Samri A, Barrou B, Autran B, et al. Investigation of human spleen dendritic cell phenotype and distribution reveals evidence of in vivo activation in a subset of organ donors. Blood. 2001;97:3470-7 pubmed
  129. Gopinath R, Hanna L, Kumaraswami V, Perumal V, Kavitha V, Vijayasekaran V, et al. Perturbations in eosinophil homeostasis following treatment of lymphatic filariasis. Infect Immun. 2000;68:93-9 pubmed
  130. Basch R, Zhang X, Dolzhanskiy A, Karpatkin S. Expression of CD41 and c-mpl does not indicate commitment to the megakaryocyte lineage during haemopoietic development. Br J Haematol. 1999;105:1044-54 pubmed
  131. Lee B, Sharron M, Montaner L, Weissman D, Doms R. Quantification of CD4, CCR5, and CXCR4 levels on lymphocyte subsets, dendritic cells, and differentially conditioned monocyte-derived macrophages. Proc Natl Acad Sci U S A. 1999;96:5215-20 pubmed
  132. Schiff D, Rae J, Martin T, Davis B, Curnutte J. Increased phagocyte Fc gammaRI expression and improved Fc gamma-receptor-mediated phagocytosis after in vivo recombinant human interferon-gamma treatment of normal human subjects. Blood. 1997;90:3187-94 pubmed
  133. Genc K, Dona D, Reder A. Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy. J Clin Invest. 1997;99:2664-71 pubmed